| Product Code: ETC10079111 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Multiple Sclerosis Drugs Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Multiple Sclerosis Drugs Market - Industry Life Cycle |
3.4 Vietnam Multiple Sclerosis Drugs Market - Porter's Five Forces |
3.5 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Vietnam Multiple Sclerosis Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about multiple sclerosis in Vietnam |
4.2.2 Growing healthcare infrastructure and access to treatment options |
4.2.3 Rising prevalence of multiple sclerosis cases in the country |
4.3 Market Restraints |
4.3.1 Limited availability of advanced treatment options for multiple sclerosis in Vietnam |
4.3.2 High cost associated with multiple sclerosis drugs |
4.3.3 Lack of skilled healthcare professionals specialized in multiple sclerosis treatment |
5 Vietnam Multiple Sclerosis Drugs Market Trends |
6 Vietnam Multiple Sclerosis Drugs Market, By Types |
6.1 Vietnam Multiple Sclerosis Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, By Interferon Beta, 2021- 2031F |
6.1.4 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, By Mixed Polymers, 2021- 2031F |
6.1.5 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, By NF-kB Inhibitor, 2021- 2031F |
6.1.6 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.7 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Vietnam Multiple Sclerosis Drugs Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, By Relapsng-remitting MS (RRMS), 2021- 2031F |
6.2.3 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, By Primar-progressive MS (PPMS), 2021- 2031F |
6.2.4 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, By Secondary-progressive MS (SPMS), 2021- 2031F |
6.2.5 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, By Progressive-relapsng MS (PRMS), 2021- 2031F |
6.3 Vietnam Multiple Sclerosis Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, By Prenteral, 2021- 2031F |
6.3.3 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4 Vietnam Multiple Sclerosis Drugs Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, By Retail Pharmacies & Drug Stores, 2021- 2031F |
6.4.4 Vietnam Multiple Sclerosis Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Vietnam Multiple Sclerosis Drugs Market Import-Export Trade Statistics |
7.1 Vietnam Multiple Sclerosis Drugs Market Export to Major Countries |
7.2 Vietnam Multiple Sclerosis Drugs Market Imports from Major Countries |
8 Vietnam Multiple Sclerosis Drugs Market Key Performance Indicators |
8.1 Number of healthcare facilities offering multiple sclerosis treatment |
8.2 Percentage of multiple sclerosis patients receiving timely diagnosis and treatment |
8.3 Investment in research and development of new multiple sclerosis drugs |
8.4 Number of educational programs and initiatives to raise awareness about multiple sclerosis |
9 Vietnam Multiple Sclerosis Drugs Market - Opportunity Assessment |
9.1 Vietnam Multiple Sclerosis Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Vietnam Multiple Sclerosis Drugs Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Vietnam Multiple Sclerosis Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Vietnam Multiple Sclerosis Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Vietnam Multiple Sclerosis Drugs Market - Competitive Landscape |
10.1 Vietnam Multiple Sclerosis Drugs Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Multiple Sclerosis Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here